R M Dixon

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi request reprint NMR studies of phospholipid metabolism in hepatic lymphoma
    R M Dixon
    MRC Biochemical and Clinical Magnetic Resonance Unit, John Radcliffe Hospital, Oxford, UK
    NMR Biomed 11:370-9. 1998
  2. ncbi request reprint Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease
    Ruth M Dixon
    MRC Biochemical and Clinical Magnetic Resonance Unit, Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK
    Brain 125:2332-41. 2002
  3. ncbi request reprint Metabolic abnormalities in developmental dyslexia detected by 1H magnetic resonance spectroscopy
    C Rae
    MRC Biochemical and Clinical Magnetic Resonance Unit, John Radcliffe Hospital, Oxford, UK
    Lancet 351:1849-52. 1998
  4. pmc Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy
    R M Dixon
    MRC Biochemical and Clinical Magnetic Resonance Unit, John Radcliffe Hospital, Oxford, UK
    Br J Cancer 63:953-8. 1991
  5. pmc Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro
    C P Thomas
    Department of Biochemistry, University of Oxford, UK
    Br J Cancer 69:633-40. 1994
  6. ncbi request reprint Brain biochemistry in Duchenne muscular dystrophy: a 1H magnetic resonance and neuropsychological study
    C Rae
    MRC Biochemical and Clinical Magnetic Resonance Spectroscopy Unit, John Radcliffe Hospital, Headington, Oxford, UK
    J Neurol Sci 160:148-57. 1998
  7. ncbi request reprint Hypo-osmotic swelling-activated release of organic osmolytes in brain slices: implications for brain oedema in vivo
    J H Bothwell
    MRC Biochemical and Clinical Magnetic Resonance Unit, Department of Biochemistry, University of Oxford, Oxford, UK
    J Neurochem 77:1632-40. 2001
  8. pmc Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer
    D J Propper
    ICRF Medical Oncology Unit, Churchill Hospital, Headington, Oxford, UK
    Br J Cancer 82:1776-82. 2000
  9. ncbi request reprint Daytime liver glycogen accumulation, measured by 13C magnetic resonance spectroscopy, in young children with Type 1 diabetes mellitus
    K Matyka
    University Department of Paediatrics, John Radcliffe Hospital, Oxford, UK
    Diabet Med 18:659-62. 2001
  10. doi request reprint A double-blind, randomized, placebo-controlled, single-dose study of the cyclooxygenase-2 inhibitor, GW406381, as a treatment for acute migraine
    A L Wentz
    Migraine Clinical Development, Neurosciences Medicines Development Center, GlaxoSmithKline, NC, USA
    Eur J Neurol 15:420-7. 2008

Collaborators

  • C Rae
  • J F Stein
  • A M Blamire
  • K K Bhakoo
  • A David Smith
  • M Tian
  • A Mohn
  • D B Dunger
  • A L Harris
  • A L Wentz
  • J H Bothwell
  • P Styles
  • K Matyka
  • B Rajagopalan
  • D J Propper
  • T B Jimenez
  • Steve Wheeler
  • Markus Farkkila
  • Curtis Schreiber
  • S K Aurora
  • Hartmut Goebel
  • Carol Foster
  • Ruediger Schellenberg
  • Suzanne N Christie
  • M Gold
  • Rose Giammarco
  • Wayne W Shtybel
  • Lucian D Sitwell
  • Guy Chouinard
  • Carlo Lisotto
  • Biagio Panascia
  • Jerry J Tomasovic
  • P H M Pop
  • T J Tacke
  • James Aldelman
  • Beate Moeckesch
  • Royale Anspach
  • Giovanni Mazzotta
  • Werner Becker
  • Gordon F Mackie
  • Steven K Elliott
  • Gary Shapero
  • Juan Pareja
  • Miquel Aguilar
  • David B King
  • Jarmo Liukkonen
  • Annette Beckmann Reinholdt
  • Ana Belen Caminero
  • Michael Tuchman
  • Pasquale Montagna
  • Tanya Bilchik
  • Scott L Meyers
  • Nicole Giguere
  • Michael Ueberall
  • Erkki Sako
  • Gary Ishkanian
  • Volker Pfaffenrath
  • Egilius Spierings
  • E Shmueli
  • C H Thompson
  • T S Ganesan
  • N C Levitt
  • J P Braybrooke
  • D C Talbot
  • T J Littlewood
  • C P Thomas
  • G K Radda
  • S A Butler
  • C J Counsell
  • J K Bradley
  • G E Adams

Detail Information

Publications10

  1. ncbi request reprint NMR studies of phospholipid metabolism in hepatic lymphoma
    R M Dixon
    MRC Biochemical and Clinical Magnetic Resonance Unit, John Radcliffe Hospital, Oxford, UK
    NMR Biomed 11:370-9. 1998
    ..The increase in phosphoethanolamine in the lymphomatous liver was not found to be due to increased flux through the synthetic pathway to phosphatidylethanolamine, nor was it due to increased availability of ethanolamine...
  2. ncbi request reprint Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease
    Ruth M Dixon
    MRC Biochemical and Clinical Magnetic Resonance Unit, Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK
    Brain 125:2332-41. 2002
    ..In our cohort, the differences were more significant for the left hippocampus...
  3. ncbi request reprint Metabolic abnormalities in developmental dyslexia detected by 1H magnetic resonance spectroscopy
    C Rae
    MRC Biochemical and Clinical Magnetic Resonance Unit, John Radcliffe Hospital, Oxford, UK
    Lancet 351:1849-52. 1998
    ..We wanted to find out whether the neurological and physiological deficits manifested as biochemical changes in the brain...
  4. pmc Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy
    R M Dixon
    MRC Biochemical and Clinical Magnetic Resonance Unit, John Radcliffe Hospital, Oxford, UK
    Br J Cancer 63:953-8. 1991
    ..Eleven patients were studied again after chemotherapy, and those with initially raised PME/ATP and PME/Pi ratios all showed a decrease in these ratios towards normal. The patients with initially normal ratios showed no changes...
  5. pmc Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro
    C P Thomas
    Department of Biochemistry, University of Oxford, UK
    Br J Cancer 69:633-40. 1994
    ..We propose that this ratio can be used as a non-invasive measure of the degree of lymphomatous infiltration in vivo...
  6. ncbi request reprint Brain biochemistry in Duchenne muscular dystrophy: a 1H magnetic resonance and neuropsychological study
    C Rae
    MRC Biochemical and Clinical Magnetic Resonance Spectroscopy Unit, John Radcliffe Hospital, Headington, Oxford, UK
    J Neurol Sci 160:148-57. 1998
    ..The possible interpretations of these metabolic changes are discussed...
  7. ncbi request reprint Hypo-osmotic swelling-activated release of organic osmolytes in brain slices: implications for brain oedema in vivo
    J H Bothwell
    MRC Biochemical and Clinical Magnetic Resonance Unit, Department of Biochemistry, University of Oxford, Oxford, UK
    J Neurochem 77:1632-40. 2001
    ..In addition, the acidification of an intracellular compartment was observed during hypo-osmotic superfusion. Our results suggest a link between brain energy reserve and brain osmoregulation...
  8. pmc Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer
    D J Propper
    ICRF Medical Oncology Unit, Churchill Hospital, Headington, Oxford, UK
    Br J Cancer 82:1776-82. 2000
    ..However, BW12C in combination with MMC for 5-FU-resistant colorectal cancer is not an effective regimen. This could be related to drug resistance rather than a failure to enhance cytotoxicity...
  9. ncbi request reprint Daytime liver glycogen accumulation, measured by 13C magnetic resonance spectroscopy, in young children with Type 1 diabetes mellitus
    K Matyka
    University Department of Paediatrics, John Radcliffe Hospital, Oxford, UK
    Diabet Med 18:659-62. 2001
    ....
  10. doi request reprint A double-blind, randomized, placebo-controlled, single-dose study of the cyclooxygenase-2 inhibitor, GW406381, as a treatment for acute migraine
    A L Wentz
    Migraine Clinical Development, Neurosciences Medicines Development Center, GlaxoSmithKline, NC, USA
    Eur J Neurol 15:420-7. 2008
    ..Both active treatments were well tolerated. Single-dose GW406381 (70 mg) and naproxen sodium (825 mg) were effective and well tolerated in the treatment of acute migraine...